IASO BioMed, Inc.
company.status.inactiveCIK 1662907fmd_1CPVSDKM3QTQY973YYGP4RQ36XManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2016 to Sep 30, 2019, 15 periods
Latest annual · FY2018
Millions- Operating income
- (2)
- Net income
- (2)
Latest quarter · Q3 FY2019
Millions- Operating income
- (0)
- Net income
- (0)
IASO BioMed, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2018 | FY2017 | Change | Source |
|---|---|---|---|---|
| Operating income | -$1.6 million | -$714,404 | 10-K 2019-04-24 · proof | |
| Net income | -$1.6 million | -$716,413 | 10-K 2019-04-24 · proof | |
| Cash from operating activities | -$291,707 | -$262,000 | 10-K 2019-04-24 · proof | |
| Total assets | $141,685 | $21,753 | +551.3% | 10-K 2019-04-24 · proof |
| Total liabilities | $744,204 | $314,130 | +136.9% | 10-K 2019-04-24 · proof |
| Cash and cash equivalents | $140,234 | $20,191 | +594.5% | 10-K 2019-04-24 · proof |
- What was IASO BioMed, Inc.'s operating income in fiscal 2018?
- IASO BioMed, Inc. reported operating income of -$1.6 million for fiscal 2018 (the year ended Dec 31, 2018), against -$714,404 the year before. Source: the 10-K filed with the SEC on Apr 24, 2019. SEC
- What was IASO BioMed, Inc.'s net income in fiscal 2018?
- IASO BioMed, Inc. reported net income of -$1.6 million for fiscal 2018 (the year ended Dec 31, 2018), against -$716,413 the year before. Source: the 10-K filed with the SEC on Apr 24, 2019. SEC
- What was IASO BioMed, Inc.'s cash from operating activities in fiscal 2018?
- IASO BioMed, Inc. reported cash from operating activities of -$291,707 for fiscal 2018 (the year ended Dec 31, 2018), against -$262,000 the year before. Source: the 10-K filed with the SEC on Apr 24, 2019. SEC
- What are IASO BioMed, Inc.'s total assets?
- As of Dec 31, 2018, IASO BioMed, Inc. reported total assets of $141,685, against $21,753 a year earlier (+551.3%). Source: the 10-K filed with the SEC on Apr 24, 2019. SEC
- What are IASO BioMed, Inc.'s total liabilities?
- As of Dec 31, 2018, IASO BioMed, Inc. reported total liabilities of $744,204, against $314,130 a year earlier (+136.9%). Source: the 10-K filed with the SEC on Apr 24, 2019. SEC
- What are IASO BioMed, Inc.'s cash and cash equivalents?
- As of Dec 31, 2018, IASO BioMed, Inc. reported cash and cash equivalents of $140,234, against $20,191 a year earlier (+594.5%). Source: the 10-K filed with the SEC on Apr 24, 2019. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1662907&period_type=annual&limit=5"Information only, not investment advice.